Biomerica Inc Total Liabilities
Biomerica Inc total liabilities. Based on the latest financial reports, Biomerica Inc (BMRA) has total liabilities worth $4.13 Million USD as of May 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Biomerica Inc (BMRA) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Biomerica Inc (1986–2026)
Total liabilities of Biomerica Inc from 1986 to 2026. This chart illustrates how Biomerica Inc's total liabilities have evolved over time, based on quarterly financial data. Explore Biomerica Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.
Biomerica Inc Competitors by Total Liabilities
The table below lists competitors of Biomerica Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Manhattan Corporation Limited
F:32U
|
Germany | €230.23K |
|
Augros Cosmetic Packaging SA
PA:AUGR
|
France | €12.18 Million |
|
Cerberus Cyber Sentinel Corp
NASDAQ:CISO
|
USA | $11.20 Million |
|
2020 Bulkers Ltd.
F:0FF
|
Germany | €121.80 Million |
|
BioLine RX Ltd
TA:BLRX
|
Israel | ILA16.75 Million |
|
Akbar Indomakmur Stimec Tbk
JK:AIMS
|
Indonesia | Rp4.84 Billion |
|
ZHONGLIANG HLDG HD-01
F:3ZH
|
Germany | €99.74 Billion |
|
Visgeneer
TWO:4197
|
Taiwan | NT$130.36 Million |
Liability Composition Analysis (1986–2026)
This chart breaks down Biomerica Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Biomerica Inc balance sheet assets.
Liquidity & Leverage Metrics
Biomerica Inc Total Liabilities Ratios Explained
Biomerica Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.62 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.57 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.61 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Biomerica Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Biomerica Inc (1986–2026)
The table below shows the annual total liabilities of Biomerica Inc from 1986 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-05-31 | $4.13 Million | +124.40% |
| 2025-05-31 | $1.84 Million | -30.90% |
| 2024-05-31 | $2.66 Million | -2.45% |
| 2023-05-31 | $2.73 Million | -10.48% |
| 2022-05-31 | $3.05 Million | +17.66% |
| 2021-05-31 | $2.59 Million | -14.93% |
| 2020-05-31 | $3.05 Million | +140.97% |
| 2019-05-31 | $1.26 Million | +40.99% |
| 2018-05-31 | $896.81K | +69.57% |
| 2017-05-31 | $528.87K | +4.51% |
| 2016-05-31 | $506.03K | -3.42% |
| 2015-05-31 | $523.93K | -5.74% |
| 2014-05-31 | $555.84K | -0.72% |
| 2013-05-31 | $559.89K | -5.47% |
| 2012-05-31 | $592.29K | -5.24% |
| 2011-05-31 | $625.01K | -34.37% |
| 2010-05-31 | $952.30K | +18.43% |
| 2009-05-31 | $804.09K | -34.29% |
| 2008-05-31 | $1.22 Million | -16.86% |
| 2007-05-31 | $1.47 Million | +7.87% |
| 2006-05-31 | $1.36 Million | -39.56% |
| 2005-05-31 | $2.26 Million | +9.90% |
| 2004-05-31 | $2.05 Million | -10.76% |
| 2003-05-31 | $2.30 Million | +16.21% |
| 2002-05-31 | $1.98 Million | +8.41% |
| 2001-05-31 | $1.83 Million | -0.01% |
| 2000-05-31 | $1.83 Million | +14.22% |
| 1999-05-31 | $1.60 Million | +23.08% |
| 1998-05-31 | $1.30 Million | -13.33% |
| 1997-05-31 | $1.50 Million | -25.00% |
| 1996-05-31 | $2.00 Million | -23.08% |
| 1995-05-31 | $2.60 Million | -13.33% |
| 1994-05-31 | $3.00 Million | -14.29% |
| 1993-05-31 | $3.50 Million | -14.63% |
| 1992-05-31 | $4.10 Million | -14.58% |
| 1991-05-31 | $4.80 Million | +9.09% |
| 1990-05-31 | $4.40 Million | +780.00% |
| 1989-05-31 | $500.00K | -28.57% |
| 1988-05-31 | $700.00K | -58.82% |
| 1987-05-31 | $1.70 Million | +21.43% |
| 1986-05-31 | $1.40 Million | -- |
About Biomerica Inc
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing of diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases in North America, Asia, Europe, the Middle East, and South America. The company offers diagnostic test kits are used to analyze blood, urine, nasal, or fecal material from patients… Read more